Results of NCCTG phase II trial of the mTOR inhibitor RAD-001 in metastatic melanoma
- Citation:
- J Clin Oncol vol 25 (18s) abstr 8530
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2836
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- R. D. Rao J. B. Allred H. E. Windschitl W. J. Maples R. R. Mcwilliams E. T. Creagan J. S. Kaur M. K. Gornet B. A. Pockaj S. N. Markovic
- Networks:
- Study
- NCCTG-N0377
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: